NRC Health (NRC) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
29 Apr, 2026Executive summary
Annual Meeting scheduled for June 23, 2026, with virtual participation and voting options available online, by phone, or by mail.
Seven directors are up for election for one-year terms following the recent declassification of the Board.
Proposals include ratification of KPMG LLP as auditor, advisory vote on executive compensation, and three amendments to the certificate of incorporation.
Significant leadership changes occurred in 2025, including a new CEO and CFO, with compensation aligned to new strategic objectives.
Voting matters and shareholder proposals
Election of seven directors to serve until the 2027 annual meeting.
Ratification of KPMG LLP as independent registered public accounting firm for 2026.
Advisory vote to approve executive compensation (say-on-pay).
Amendments to the certificate of incorporation: (1) remove supermajority voting requirements, (2) allow removal of directors without cause, (3) change written consent voting from unanimous to majority.
Board of directors and corporate governance
Board declassified in April 2026; all directors now elected annually.
Five of seven directors are independent; diversity includes women and ethnic minorities.
Lead director role established; Board committees include Audit, Compensation and Talent, Nominating, and Strategic Planning.
Proxy access allows eligible shareholders to nominate directors.
Latest events from NRC Health
- Strong recurring revenue, AI-driven growth, and a major new client highlight future momentum.NRC
16th Annual East Coast IDEAS Conference10 Jun 2026 - Record recurring contract value and AI-driven growth fuel strong financial and market performance.NRC
Investor presentation9 Jun 2026 - High-quality rounding and improved communication drive stronger patient loyalty outcomes.NRC
Status update27 May 2026 - Key votes include director elections, auditor ratification, and major governance amendments.NRC
Proxy filing8 May 2026 - Proxy seeks approval for board declassification, governance reforms, and executive compensation changes.NRC
Proxy filing8 May 2026 - Record TRCV, 4% revenue growth, and the largest contract ever signed; $9.4M Q2 expense expected.NRC
Q1 20266 May 2026 - Q4 2025 revenue rose 2%, TRCV up 8% YoY, and a $0.16 dividend was declared.NRC
Q4 20253 Feb 2026 - Huey AI enhances healthcare experience management with tailored, ethical, and privacy-focused solutions.NRC
Status Update3 Feb 2026 - Timely, representative feedback and focus on key drivers accelerate patient experience improvement.NRC
Status update2 Feb 2026